Patent ID: 10370427

Abstract:
The present invention relates to specific T-cell receptor a-chains, T-cell receptor β-chains and T-cell receptors comprising said T-cell receptor a-chain and/or β-chain. In particular, the invention relates to T-cell receptors and/or chains binding to the influenza matrix peptide GILGFVFTL (GL9 peptide) presented by Human Leukocyte antigen A2 (HLA-A2) molecules. The present invention further relates to soluble TCR constructs, chimeric TCRs, nucleic acids, expression constructs and cells comprising said TCR a-chain and/or β-chain or the respective TCR. The present invention further relates to the use of the TCR a-chain and/or β-chain or the respective TCR or the soluble TCR constructs or chimeric TCRs as a medicament, preferably in the detection, prevention and/or treatment of influenza. The present invention further relates to methods of detecting, preventing and/or treating influenza.